cms_DE: 54
In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.
This data as json, copyable
|
rowid
|
facility_name
|
facility_id
|
address
|
city
|
state
|
zip
|
inspection_date
|
deficiency_tag
|
scope_severity
|
complaint
|
standard
|
eventid
|
inspection_text
|
filedate
|
| 54 |
WILLOWBROOKE COURT AT COUNTRY HOUSE |
85003 |
4830 KENNETT PIKE |
WILMINGTON |
DE |
19807 |
2019-07-15 |
755 |
D |
0 |
1 |
N66611 |
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, interview and review of facility documentation as indicated, it was determined that for one out of one death record review, the facility failed to provide routine pharmaceutical services to meet the needs of R48. Findings include: The facility pharmacy's policy entitled LTC Facilities: Receiving Pharmacy Products and Services from Pharmacy, last revised on 1/2/13, stated, .Procedure . 3. The pharmacy will provide new routine and PRN medication orders the same day, unless the medication would be started until the next day. 5/28/19 - The hospital's Medication Orders Upon Discharge stated to administer to R48 the following medications: [REDACTED] - [MEDICATION NAME] (inhaler) twice a day, Next Dose Due: tonight 5/28; - Lacosamide (anti-[MEDICAL CONDITION]) twice a day, Next Dose Due: tonight 10 PM 5/28; - [MEDICATION NAME] (antipsychotic) at bedtime, Next Dose Due: tonight 5/28 10 PM. 5/28/19 at approximately 12:00 Noon - R48 was admitted to the facility. 5/28/19 - R48's physician Order Recap Report also stated that Calcium-Vitamin D (dietary supplement) and a nasal spray were ordered. 5/28/19 - Review of R48's (MONTH) 2019 eMAR and corresponding Order-Administration Notes revealed: - R48 did not receive [MEDICATION NAME], Lacosamide, [MEDICATION NAME], Calcium-Vitamin D and nasal spray at 8 PM as the facility was waiting for the pharmacy to deliver the medications. - At 8:58 PM, R48's [MEDICATION NAME] was discontinued by E6 (NP) for a generic equivalent medication, Breo Ellipta (inhaler), for a [DIAGNOSES REDACTED]. It was unclear in R48's clinical record why the Breo medication was ordered to start on 5/30/19 and not 5/29/19. 5/29/19 at 1:27 AM - The pharmacy's Proof of Delivery report for R48 revealed that Lacosamide, [MEDICATION NAME], nasal spray, Breo Ellipta, and Calcium with Vitamin D were delivered to the facility at this time. 5/29/19 - Review of R48's (MONTH) 2019 eMAR and corresponding Order-Administration Notes revealed: - At 8:45 PM - An Order-Administration Note, written by E24 (RN), for R48's Lacosamide stated, .Not delivered yet from (name) pharmacy. Despite having received the Lacosamide medication from the pharmacy on 5/29/19 at 1:27 AM and R48 receiving her 8 AM dose, R48 was not administered the medication at 8 PM. 7/11/19 at 9:26 AM - During an interview, E5 (Physician) stated he/she was told about R48's missing doses of his/her [MEDICAL CONDITION] medication at a later time. 7/11/19 at 12:30 PM - Findings were reviewed during the Exit Conference with E1 (NHA), E2 (former DON), E3 (interim DON) and E6 (NP). The facility failed to provide routine pharmaceutical services to meet the needs of R48. |
2020-09-01 |